AJOVista’s Mersana Therapeutics MRSN Stock Holding History

AJOVista’s Portfolio MRSN Stock Details MRSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-819	Closed	-$41.1K	–	152
2024 Q2	$41.1K	Buy	+819	New	+$59.2K	0.12%	72

Other funds holding MRSN

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AJOVista's MRSN Position: Q3 2024 in Review

AJOVista sold out of Mersana Therapeutics (MRSN) in Q3 2024, closing a stake of 819 shares — an estimated $41.1K sold.

AJOVista first reported a position in MRSN in Q2 2024 and held it in 1 quarter. The position peaked at $41.1K in Q2 2024. 113 funds tracked by Wall St. Rank hold MRSN as of Q3 2024.

AJOVista reported no remaining Mersana Therapeutics position as of Q3 2024 after selling out during the quarter.
AJOVista sold 819 Mersana Therapeutics shares in Q3 2024, an estimated $41.1K.
AJOVista first reported a position in Mersana Therapeutics in Q2 2024 and held it in 1 quarter.
AJOVista's Mersana Therapeutics position peaked at $41.1K in Q2 2024.
113 funds tracked by Wall St. Rank held Mersana Therapeutics as of Q3 2024.

Based on AJOVista's 13F filing for Q3 2024, filed 12 Nov 2024.